Presented ByDr Takayuki Yoshino, National Cancer Center Hospital East, Japan
TrialPhase 2, DESTINY-CRC01 ConferenceASCO GI 2022
TypePeer-reviewed article
21 March 2022 10:26
Presented ByDr Takayuki Yoshino, National Cancer Center Hospital East, Japan
TrialPhase 2, DESTINY-CRC01 ConferenceASCO 2021
TypePeer-reviewed article
12 August 2021 21:10
ExpertProf. Salvatore Siena, University of Milan Niguarda Cancer Center, Italy
TrialPhase 3, DESTINY-CRC01 ConferenceASCO 2020
17 September 2020 15:00